MENU

NCNA NuCana plc Forecast, Technical & Fundamental Analysis

a developer of novel anti-cancer medicines

Industry Biotechnology
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
NCNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NCNA is expected to report earnings to fall 96.57% to 0 cents per share on May 15

NuCana plc NCNA Stock Earnings Reports
Q1'24
Est.
$0.00
Q4'23
Missed
by $0.03
Q3'23
Est.
$0.00
Q2'23
Est.
$0.00
Q1'23
Est.
$0.00
The last earnings report on March 20 showed earnings per share of -3 cents, missing the estimate of 0 cents. With 82.64K shares outstanding, the current market capitalization sits at 3.48M.
A.I. Advisor
published General Information

General Information

a developer of novel anti-cancer medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Lochside Way
Phone
+44 1313571111
Employees
28
Web
https://www.nucana.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

NCNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with PIRS. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
-1.25%
PIRS - NCNA
95%
Closely correlated
-0.12%
CDTX - NCNA
93%
Closely correlated
+3.35%
NBY - NCNA
92%
Closely correlated
-8.67%
WINT - NCNA
92%
Closely correlated
-6.24%
RNAC - NCNA
92%
Closely correlated
+1.12%
More

Groups containing NCNA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
-1.25%
NCNA
(22 stocks)
26%
Poorly correlated
-2.84%
cancer
(82 stocks)
18%
Poorly correlated
-2.38%
drugs
(254 stocks)
17%
Poorly correlated
-1.72%
biotechnology
(238 stocks)
14%
Poorly correlated
-1.80%
europe
(179 stocks)
11%
Poorly correlated
-0.25%